WEDNESDAY, April 24, 2024 (HealthDay News) — A budget-busting 3.6 million Medicare recipients could now be eligible for coverage of the weight-loss drug Wegovy, a new KFF analysis says. That’s because the U.S. Food and Drug Administration has approved the use of Wegovy (semaglutide) to reduce the risk of heartContinue Reading

TUESDAY, April 23, 2024 (HealthDay News) — About six out of 10 working-age adults hit with a cancer diagnosis say it put real pressure on their financial survival, a new report finds. “Today’s findings reiterate the critical role access to affordable, quality care and paid family medical leave plays inContinue Reading